Skip to content

US · BON · CHEMICALS - SPECIALTY

Bon Natural Life Limited (BON) intrinsic value and stock valuation

$1.04as of 2026-11-21 · Mkt cap 6.39M

Data updated · price as of 2026-11-21

IC valuationIntrinsic value, upside vs price and the fair-value band are available to Pro members.
P/E
Pro
P/B
Pro
P/S
Pro

Price history

Price charts, the InvestorsCraft value line, and the fair-value band are Pro features.

Bon Natural Life Limited DCF and intrinsic value

InvestorsCraft values BON with the Chepakovich two-stage DCF model. How the model works · Run your own DCF prefilled from BON’s statements →

Bon Natural Life Limited Graham Number

The Graham Number is not defined for negative earnings or book value. Guide · Calculator →

Basic Materials · Chemicals - Specialty Xi'an, SA 710060 bnlus.com

How the business is doing

Fiscal 2018–2025, USD

Revenue
$18.7M+0.5% 5y CAGRd
20182025
Net income
-$-1.99M
20182025
Free cash flow
-$-4.23M
20182025
Total equity
$58M+39.4% 5y CAGRd
20182025

Is it expensive?

Each multiple against its own 15-year range, or against peers where no history is available

P/E
Pro
with Pro
P/B
Pro
with Pro
P/S
Pro
with Pro
EV/EBITDA
Pro
with Pro
P/EG
Pro
with Pro
P/TBV
Pro
with Pro

Peers

Same-industry companies, ranked by market cap

Peer comparison

The peer comparison table is shown only to users with a Pro subscription.

Financials

Statements by fiscal year

Fiscal 2018–2025, USD
20252024202320222021
Revenue$18.7M$23.8M$29.5M$29.9M$25.5M
Operating income-$-1.62M$1.87M$5.92M$7.91M$5.4M
Net income-$-1.99M$400K$4.6M$6.24M$4.59M
EPSd-$-721.01K$166.7K$5M$7.43M$6.85M
Operating cash flow$140K-$-7.72M-$-650K-$-190K$4.05M
Capital expenditure-$-4.37M-$-10K-$-60K-$-4.74M-$-4.75M
Free cash flow-$-4.23M-$-7.73M-$-710K-$-4.92M-$-700K
Total assets$85.2M$61.8M$46.6M$37.3M$36.4M
Total debt$12.3M$7.3M$4.21M$5.41M$3.21M
Net debt$6.06M$7.22M$4.09M$4.57M$1.31M
Total equity$58M$44.4M$36M$30.1M$26.5M
Cash and short-term investments$6.27M$80K$110K$840K$3.61M
Income statement
20252024202320222021
Revenue$18.7M$23.8M$29.5M$29.9M$25.5M
Cost of revenue$14.8M$16.7M$20.7M$20.5M$18.4M
Gross profit$3.88M$7.11M$8.84M$9.42M$7.11M
Research and development expenses$750K$1.62M$300K$420K$250K
Selling, general and administrative expenses$4.75M$3.62M$2.61M$2.4M$1.46M
Other expenses$0.00$0.00$0.00$0.00$0.00
Operating expenses$5.5M$5.24M$2.9M$1.52M$1.71M
Cost and expenses$20.3M$22M$23.6M$22M$20.1M
Interest income$0.00$0.00$10K$0.00$0.00
Interest expense$370K$300K$240K$450K$420K
Depreciation and amortization$1.29M$1.28M$1.18M$370K$290K
Ebitda-$-60K$2.3M$6.98M$8.38M$6.13M
Operating income-$-1.62M$1.87M$5.92M$7.91M$5.4M
Total other income/expenses, net-$-90K-$-1.16M-$-360K-$-400K$30K
Income before tax-$-1.71M$720K$5.55M$7.51M$5.43M
Income tax expense$340K$350K$1M$1.27M$820K
Net income-$-1.99M$400K$4.6M$6.24M$4.59M
Weighted average shares outstanding$2.76M$2.28M$920K$840K$680K
Weighted average diluted shares outstanding$2.76M$2.4M$920K$840K$670K
Balance sheet
20252024202320222021
Cash and short-term investments$6.27M$80K$110K$840K$3.61M
Net receivables$11.5M$11.8M$4.61M$6.78M$6.15M
Inventory$19.2M$1.57M$9.39M$1.72M$5.69M
Total current assets$45.8M$39.8M$24.2M$14.7M$16.6M
Property, plant and equipment, net$18.3M$15.2M$21.4M$22.2M$19.4M
Goodwill and intangible assets$6.42M$780K$1M$370K$410K
Long-term investments$14.7M$0.00$22.4M$22.5M$0.00
Total non-current assets$39.4M$22M$22.4M$22.5M$19.9M
Total assets$85.2M$61.8M$46.6M$37.3M$36.4M
Accounts payable$7.64M$3.43M$1.4M$210K$380K
Short-term debt$11.4M$6.33M$3.16M$4.89M$710K
Deferred revenue$220K$510K$110K$190K$1.1M
Total current liabilities$26.3M$16.5M$9.61M$6.65M$7.53M
Long-term debt$920K$970K$1.05M$520K$2.5M
Deferred revenue, non-current$0.00$0.00$0.00$0.00$0.00
Total non-current liabilities$880K$970K$960K$520K$2.35M
Capital lease obligations$40K$150K$90K$580K$180K
Total liabilities$27.2M$17.4M$10.6M$7.16M$9.88M
Common stock$150K$0.00$0.00$0.00$0.00
Retained earnings$16.6M$18.7M$18.7M$14.7M$9.19M
Accumulated other comprehensive income (loss)-$-30K$160K-$-1.31M-$-830K$1.27M
Total equity$58M$44.4M$36M$30.1M$26.5M
Total investments$14.7M$0.00$22.4M$22.5M$1.7M
Total debt$12.3M$7.3M$4.21M$5.41M$3.21M
Net debt$6.06M$7.22M$4.09M$4.57M$1.31M
Cash flow statement
20252024202320222021
Net income-$-1.99M$420K$4.61M$6.24M$4.59M
Depreciation and amortization$1.29M$1.28M$1.18M$370K$290K
Stock-based compensation$0.00$0.00$0.00$0.00$0.00
Change in working capital-$-1.45M-$-11.67M$250K-$-6.83M-$-650K
Accounts receivable-$-110K-$-6.81M$2.08M-$-1.3M-$-90K
Inventory-$-3.83M-$-6.12M-$-3.84M-$-560K-$-610K
Accounts payable$6.11M$1.92M$830K-$-140K-$-970K
Net cash provided by operating activities$140K-$-7.72M-$-650K-$-190K$4.05M
Investments in property, plant and equipment-$-10M-$-10K-$-730K-$-4.74M-$-4.75M
Acquisitions, net$0.00$0.00$0.00$0.00-$-1M
Net cash used for investing activities-$-10M-$-20K-$-1.19M-$-3.06M-$-7.44M
Common stock issued$10.7M$5.6M$2.03M$0.00$11.3M
Common stock repurchased$0.00$0.00$0.00$0.00$0.00
Dividends paid$0.00$0.00$0.00$0.00$0.00
Net cash used for financing activities$15.5M$8.76M$1.16M$2.26M$5.35M
Net change in cash$5.61M$550K-$-730K-$-1.06M$1.85M
Cash at end of period$6.27M$660K$110K$840K$1.9M
Operating cash flow$140K-$-7.72M-$-650K-$-190K$4.05M
Capital expenditure-$-4.37M-$-10K-$-60K-$-4.74M-$-4.75M
Free cash flow-$-4.23M-$-7.73M-$-710K-$-4.92M-$-700K
USD millions

Line items

    USD millions

    Line items

      USD millions

      Line items

        About Bon Natural Life Limited

        Bon Natural Life Limited, accompanied by its various subsidiaries, focuses on the innovation, production, and worldwide distribution of active functional compounds sourced from natural plant extracts. Its operations span the People's Republic of China and international markets. The company's diverse product range includes components for personal care items, such as plant-derived aromatic compounds supplied to manufacturers of perfumes and fragrances. It also develops natural health products, featuring powdered beverages and biologically active food ingredients primarily intended for use as food additives, as well as a variety of nutritional supplements. These offerings are predominantly utilized by industrial clients in the functional food, personal care, cosmetic, and pharmaceutical sectors. Founded in 2006, Bon Natural Life Limited's main office is located in Grand Cayman, Cayman Islands.

        CEO
        Yongwei Hu
        Employees
        96
        Beta
        -0.26

        Explore

        Frequently asked questions

        What is the intrinsic value of Bon Natural Life Limited (BON)?

        InvestorsCraft does not currently publish an intrinsic value for BON. How the IC value is calculated.

        Is BON undervalued?

        InvestorsCraft does not publish an undervaluation signal for BON at this time.

        How is the intrinsic value calculated?

        InvestorsCraft estimates intrinsic value with four methods: the Chepakovich valuation model (IC), an AI-assisted estimate, the Graham-Dodd formula, and the Graham Formula. How the IC value is calculated.

        How often is this page updated?

        Prices are refreshed each trading day; valuation inputs update when new financial statements are processed. This page was last updated Nov 21, 2026.

        Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Figures marked d are derived from the figures shown — for example upside = IC ÷ price − 1, CAGR over the last five fiscal years, and range bounds are 15-year or peer minimum and maximum.